Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neuropharmacology ; 47(2): 184-94, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15223297

ABSTRACT

Sensitization of NMDA receptors containing the NR2B subunit has been increasingly associated with various forms of synaptic plasticity, including those implicated in the pathogenesis of extrapyramidal motor dysfunction. To determine whether activation of NR2B containing receptors contributes to the development and maintenance of levodopa-induced response changes in parkinsonian animals, we evaluated the effects of the selective NR2B antagonist CP-101,606 on these response alterations in unilateral 6-hydroxydopamine (6-OHDA) lesioned rats. Three weeks of twice-daily levodopa treatment decreased the duration of the rotational response to acute levodopa challenge. The response alteration was associated with an increase in GluR1 (S831) phosphorylation in medium spiny neurons of the dorsolateral striatum. Both the attenuated rotational response and augmented GluR1 phosphorylation were decreased by CP-101,606 treatment. These CP-101,606 effects were observed when the compound was administered either at the end of chronic levodopa treatment (ameliorative effect) or together with the twice-daily levodopa treatment for 3 weeks (preventive effect). Furthermore, concurrent administration of CP-101,606 with levodopa potentiated the ability of levodopa challenge to reverse the 6-OHDA lesion-induced contralateral forelimb movement deficit as measured in a drag test. These results suggest that activation of NR2B subunit containing NMDA receptors contributes to both the development and maintenance of levodopa-induced motor response alterations, through a mechanism that involves an increase in GluR1 phosphorylation in striatal spiny neurons.


Subject(s)
Excitatory Amino Acid Antagonists/pharmacology , Levodopa/antagonists & inhibitors , Parkinson Disease, Secondary/drug therapy , Piperidines/pharmacology , Receptors, N-Methyl-D-Aspartate/drug effects , Animals , Functional Laterality/physiology , Levodopa/pharmacology , Locomotion/drug effects , Male , Neostriatum/drug effects , Oxidopamine , Parkinson Disease, Secondary/chemically induced , Phosphorylation , Rats , Rats, Sprague-Dawley , Receptors, AMPA/metabolism , Rotation , Serine/metabolism , Stereotyped Behavior/drug effects , Sympathectomy, Chemical
SELECTION OF CITATIONS
SEARCH DETAIL
...